Allergan and tribe to appeal PTAB’s immunity decision
02-03-2018
Native American tribe not entitled to sovereign immunity: PTAB
26-02-2018
Native American tribe aims to dismiss Allergan patent IPRs
26-09-2017
tumsasedgars / iStockphoto.com
Late last week, the Patent Trial and Appeal Board (PTAB) rejected a Native American tribe’s attempt to dismiss inter partes reviews (IPRs) based on the tribe’s sovereign immunity claims.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
generics, Restasis, patent invalidation, Allergan, Saint Regis Mohawk Tribe, PTAB, IPR, sovereign immunity
